Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Pfizer Inc. (NYSE: PFE) Seeking US Approval for COVID-19 Vaccine In…
Kintara Therapeutics (NASDAQ: KTRA) Posted Net Loss of $1.6 Per Share…
Turning Point Therapeutics Inc. (NASDAQ: TPTX) Receive Breakthrough Designation For Repotrectinib…
Timber Pharmaceuticals Inc. (NYSEAMERICAN: TMBR) Announce Encouraging Top-Line Results Evaluating TMB-001…
Brickell Biotech Inc. (NASDAQ: BBI) Release Encouraging Topline Results From Phase…
Finance
Altimmune Inc. (NASDAQ: ALT) Announces Promising First Phase Pemvidutide Study Results…
Ziopharm Oncology Inc. NASDAQ: ZIOP) Announce Strategic Reorganisation and Cash…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Submits Clinical…
NovaBay Pharmaceuticals Inc. (NYSEAMERICAN: NBY) Signs Agreement To Acquire $15 Million…
Tonix Pharmaceuticals Holding Corp’s (NASDAQ: TNXP) Oral Presentation Accepted At ACR…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pfizer Inc. (NYSE: PFE) Seeking US Approval for COVID-19 Vaccine In Children below 12 years
Ward Sport
-
October 15, 2021
Kintara Therapeutics (NASDAQ: KTRA) Posted Net Loss of $1.6 Per Share in Fiscal 2021
Turning Point Therapeutics Inc. (NASDAQ: TPTX) Receive Breakthrough Designation For Repotrectinib in Solid Tumors
Timber Pharmaceuticals Inc. (NYSEAMERICAN: TMBR) Announce Encouraging Top-Line Results Evaluating TMB-001 in Congenital Ichthyosis
Brickell Biotech Inc. (NASDAQ: BBI) Release Encouraging Topline Results From Phase 3 Cardigan I & II Studies
The Next Biotech Winners After the Vaccine Bubble Burst (ATRX, INMB,...
Gavins Felicity
-
October 14, 2021
0
Voyager Therapeutics Inc. (NASDAQ: VYGR) And Pfizer Inc. (NYSE: PFE) Enter...
Kate Hudson
-
October 14, 2021
0
Vaxart Inc. (NASDAQ: VXRT) Commences Phase II Clinical Trial For its...
Kate Hudson
-
October 13, 2021
0
MannKind Corporation (NASDAQ: MNKD) Starts Paediatric Enrolment For INHALE-1 Study ...
Matt Wade
-
October 13, 2021
0
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Enters a Note Purchase Agreement And...
Kate Hudson
-
October 13, 2021
0
Aditxt Inc (NASDAQ: ADTX) Announces that the Group Will Acquire the...
Kate Hudson
-
October 12, 2021
0
Xeris Pharmaceuticals (NASDAQ: XERS) Announces that it has Completed the Acquisition...
Matt Wade
-
October 11, 2021
0
Annovis Bio Inc (NYSEAMERICAN: ANVS), Cassava Sciences Inc (NASDAQ: SAVA), Honest...
Kate Hudson
-
October 11, 2021
0
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has Acquired New R&D Center
Gavins Felicity
-
October 11, 2021
0
Impel NeuroPharma Inc. (NASDAQ: IMPL) Launches Trudhesa Nasal Spray For Prescription...
Kate Hudson
-
October 8, 2021
0
1
2
3
...
107
Page 1 of 107
Close
